EASTROC (Stock Code: 09980) saw its shares rise more than 5% on its second day of trading, reaching an intraday high of HKD 265, pushing its total market capitalization close to HKD 150 billion. At the time of writing, the stock was up 4.53%, trading at HKD 263.20, with a turnover of HKD 430 million.

EASTROC commenced trading on the Hong Kong Stock Exchange on February 3rd. GF Securities highlighted that the cornerstone investors for the Hong Kong listing include several world-renowned investment institutions, such as the Qatar Investment Authority, Singapore's sovereign wealth fund Temasek, BlackRock, UBS Global Asset Management, J.P. Morgan Asset Management, and Fidelity, underscoring strong capital market confidence in the company's solid fundamentals.

It is noteworthy that the company has entered into a strategic cooperation agreement with the Indonesian Chinese conglomerate, Salim Group. EASTROC will invest up to USD 200 million to establish a joint venture named Indonesia EASTROC Vitamin Functional Beverage Company. The total investment for this collaboration is projected to be USD 300 million, with capital contributions scheduled across six phases, and the partnership will be exclusive for the next five years. Analysts from Pacific Food and Beverage noted in a related research report that, based on the scale and competitive landscape of the energy drink industry across Southeast Asian countries, EASTROC's expansion into the region holds promising potential to achieve revenue of CNY 5 billion in the medium to long term.